<ѻý>ASCVD Mortality Linked to Specific Air Pollution Sourcesѻý> Pollution-mortality relationship evidenced at the level of PM2.5 source type Nov 27, 2024
<ѻý>Brain Volume Changes Come 10 Years Sooner for Men With Cardiovascular Risksѻý> Men faced neurodegeneration a decade earlier than women Nov 26, 2024
<ѻý>Hunting & Heart Attacks; Cardiologist's Whistleblower Suit; Algorithm Predicts Deathѻý> Recent developments of interest in cardiovascular medicine Nov 26, 2024
<ѻý>Acoramidis Snags FDA Approval for ATTR Cardiomyopathyѻý> Another pricey TTR stabilizer to hit shelves Nov 25, 2024
<ѻý>Medications to Reduce Lipoprotein(a); Genome Models and CVD Riskѻý> Also in TTHealthWatch: genetic testing of couples planning pregnancy Nov 23, 2024 podcast
<ѻý>Metformin, Lifestyle Changes Fail to Reduce Afib Burdenѻý> Standard of care prevails in single-center trial Nov 20, 2024
<ѻý>Sacubitril/Valsartan Curbs Cardiotoxicity From Chemotherapyѻý> Benefit shown in trial of patients flagged for high risk of cardiotoxicity Nov 20, 2024
<ѻý>More Lp(a)-Reducing Tx; Cardiac Denervation for Afib; LAA Occluders at 5 Yearsѻý> Recent developments of interest in cardiovascular medicine Nov 19, 2024
<ѻý>Nasal Spray Diuretic Shows Potential for Heart Failure in Trial of Healthy Adultsѻý> Intranasal bumetanide demonstrated safety, bioequivalence with its oral and IV counterparts Nov 19, 2024
<ѻý>Reused Pacemakers Good as New in Early Safety Dataѻý> No excess infections when pacemakers were cleaned and repackaged for resource-deprived patients Nov 18, 2024
<ѻý>Over 50% of U.S. Adults Qualify for Ozempic, Wegovyѻý> Most are eligible for weight management indication Nov 18, 2024
<ѻý>Study: Statins Mitigate Heart Risks From JAK Inhibitorsѻý> Is this the final finding from ORAL Surveillance? Don't count on it. Nov 18, 2024
<ѻý>Left Atrial Appendage Closure Reduced Bleeding After Afib Ablationѻý> Procedure also noninferior to anticoagulation for death, stroke, or systemic embolism composite Nov 18, 2024
<ѻý>Spironolactone Misses the Mark in Acute MI Without HFѻý> Drug discontinuations may have leveled any benefit in CLEAR OASIS 9 trial Nov 17, 2024
<ѻý>Is DOAC a Viable Option After Bioprosthetic Valve Surgery Even in Sinus Rhythm?ѻý> Japanese trial supports use but event risk might be low enough to suggest a different strategy Nov 17, 2024
<ѻý>Big Blow to Anticoagulation Strategy Against Afib-Related Cognition Problemsѻý> Microemboli now questioned as driver of cognitive impairment in atrial fibrillation Nov 17, 2024
<ѻý>Novel CRISPR-Cas9-Based Promising in ATTR Cardiomyopathyѻý> One-time treatment with nexiguran ziclumeran tied to decline in serum TTR levels in phase I trial Nov 17, 2024
<ѻý>Tirzepatide Officially Puts GLP-1 Meds on the Map for Heart Failure Benefitѻý> SUMMIT trial able to show clinical benefit beyond quality-of-life improvement Nov 16, 2024
<ѻý>Larger Study Supports Safety of Tetracyclines During Early Pregnancyѻý> Jury is still out, however, without more rigorous evidence Nov 14, 2024
<ѻý>New Rescuer Guidelines Tackle Rise of Drowning Deaths in U.S.ѻý> American Heart Association, American Academy of Pediatrics stress CPR with breaths, compressions Nov 12, 2024
<ѻý>Post-Pandemic OHCA Survival Down; Vitamin D Supplements & BP; Varipulse PFA Approvedѻý> Recent developments of interest in cardiovascular medicine Nov 12, 2024
<ѻý>Who Needs a Defibrillator After MI? FDA Recs on Inferior Vena Cava Filtersѻý> Also in TTHealthWatch: early sugar exposure, hypertension, and diabetes Nov 09, 2024 podcast
<ѻý>Zepbound's Weight Loss, Cardiometabolic Benefits Hold Up at 3 Yearsѻý> Nearly all participants in SURMOUNT-1 avoided diabetes with the GLP-1/GIP receptor agonist Nov 07, 2024
<ѻý>Simple Measures Ease Cardiac Strain in 100-Degree Weatherѻý> But electric fans were associated with harm in a hot and dry setting Nov 07, 2024
<ѻý>Mixed Bag for Clinicians Vying for House Seatsѻý> Some races still too close to call Nov 06, 2024
<ѻý>Tricuspid Valve Replacement Finds Surer Footing With TRISCEND II's 1-Year Reportѻý> Evoque device helped outcomes in severe tricuspid regurgitation, with some safety caveats Oct 31, 2024
<ѻý>Colchicine Goes Belly-Up in a More Definitive Heart Attack Trialѻý> Larger CLEAR OASIS 9 trial could not replicate past results Oct 30, 2024
<ѻý>Cold Weather Heart Attacks; Preemptive Valve Procedures Flop; Better Bleeding Scoreѻý> Recent developments of interest in cardiovascular medicine Oct 29, 2024
<ѻý>SGLT2 Inhibitor Carry-Over Benefits Last How Long?ѻý> Trial follow-up defines the need for long-term treatment in protecting the kidneys and heart Oct 29, 2024
<ѻý>Stent-Like Hybrid on Track for Lofty Long-Term Goals in PCIѻý> Stent-related events plateaued 6 months after DynamX implant Oct 28, 2024
<ѻý>Major Win for Preemptive TAVR in Symptomless Aortic Stenosisѻý> Larger pool of TAVR candidates suggested by EARLY TAVR trial results Oct 28, 2024
<ѻý>Private Equity's Tighter Grip; ApoB Inhibitors vs Liver? Promising New RDN Systemѻý> Recent developments of interest in cardiovascular medicine Oct 22, 2024
<ѻý>IV Fluid Shortage May Impact Surgeries Around the U.S. for Weeksѻý> Hurricane-related damage keeps sterile fluids factory shut down Oct 22, 2024
<ѻý>No X-Ray Proof of Rare Surgical Complication Tied to GLP-1 Agonistsѻý> Conundrum of holding meds continues following conflicting reports of aspiration events Oct 22, 2024
<ѻý>Stroke Prevention Guideline Adds Recs for GLP-1 Drugs, Gender-Affirming Careѻý> Recommendation updates also address social determinants of health Oct 21, 2024
<ѻý>Case Against Perioperative Beta-Blockers Grows Strongerѻý> Excess postoperative strokes, and accompanying racial disparities, tied to any beta-blocker use Oct 20, 2024
<ѻý>COVID's Outsized Heart Risk; Prehab for Cardiac Surgery; Telerobotic Valve Repairѻý> Recent developments of interest in cardiovascular medicine Oct 15, 2024
<ѻý>Protein Drivers of Heart Attack Risk Disproportionately Affect Womenѻý> Study suggests mechanistic underpinnings of known sex disparities in MI Oct 14, 2024
<ѻý>Do Lipid Values in Adolescence Improve CVD Risk Prediction?ѻý> Including lipids did not prove superior to non-laboratory-based criteria alone, study finds Oct 14, 2024